{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:04:00Z","timestamp":1778839440257,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Highly sensitized candidates on the transplant waitlist remain a significant challenge, as current desensitization protocols have variable success rates of donor-specific antibody (DSA) reduction. Therefore, improved therapies are needed. A proliferation-inducing ligand (APRIL) and B-lymphocyte stimulator (BLyS) are critical survival factors for B-lymphocytes and plasma cells, which are the primary sources of alloantibody production. We examined the effect of APRIL\/BLyS blockade on DSA in a murine kidney transplant model as a possible novel desensitization strategy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>C57BL\/6 mice were sensitized with intraperitoneal (IP) injections of 2 \u00d7 10<jats:sup>6<\/jats:sup> BALB\/c splenocytes. Twenty-one days following sensitization, animals were treated with 100 \u03bcg of BLyS blockade (B-cell activating factor receptor-immunoglobulin) or APRIL\/BLyS blockade (transmembrane activator and calcium modulator and cyclophilin ligand interactor-immunoglobulin), administered thrice weekly for an additional 21 days. Animals were then euthanized or randomized to kidney transplant with Control Ig, BLyS blockade, or APRIL\/BLyS blockade. Animals were euthanized 7 days posttransplant. B-lymphocytes and DSA of BLyS blockade only or APRIL\/BLyS blockade-treated mice were assessed by flow cytometry, immunohistochemistry, and enzyme-linked immunospot.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>APRIL\/BLyS inhibition resulted in a significant reduction of DSA by flow crossmatch compared with controls (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). APRIL\/BLyS blockade also significantly depleted IgM- and IgG-secreting cells and B-lymphocyte populations compared to controls (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). APRIL\/BLyS blockade in transplanted mice also resulted in decreased B-lymphocyte populations; however, no difference in rejection rates were seen between groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>APRIL\/BLyS blockade with transmembrane activator and calcium modulator and cyclophilin ligand interactor-immunoglobulin significantly depleted B-lymphocytes and reduced DSA in this sensitized murine model. APRIL\/BLyS inhibition may be a clinically useful desensitization strategy for sensitized transplant candidates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002686","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T04:21:23Z","timestamp":1552450883000},"page":"1372-1384","source":"Crossref","is-referenced-by-count":13,"title":["APRIL\/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice"],"prefix":"10.1097","volume":"103","author":[{"given":"Nancy A.","family":"Wilson","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie M.","family":"Bath","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bret M.","family":"Verhoven","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney A.","family":"Boldt","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Sukhwal","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Wisconsin\u2013Platteville, Platteville, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixiong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Panzer","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Redfield","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Wisconsin\u2013Madison, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients.","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MOT.0000000000000128","article-title":"Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches.","volume":"19","author":"Jordan","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2369-14-217","article-title":"An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival.","volume":"14","author":"Scornik","year":"2013","journal-title":"BMC Nephrol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival.","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(16)31595-1","article-title":"Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.","volume":"389","author":"Manook","year":"2017","journal-title":"Lancet"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1612567","article-title":"Igg endopeptidase in highly sensitized patients undergoing transplantation.","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation.","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization.","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ctr.12335","article-title":"Desensitization in kidney transplantation: review and future perspectives.","volume":"28","author":"Abu Jawdeh","year":"2014","journal-title":"Clin Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4049\/jimmunol.1002873","article-title":"Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes.","volume":"186","author":"Parsons","year":"2011","journal-title":"J Immunol"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.coi.2011.07.011","article-title":"Essential role for B cells in transplantation tolerance.","volume":"23","author":"Redfield","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","article-title":"TACI-ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking blys.","volume":"15","author":"Gross","year":"2001","journal-title":"Immunity"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1126\/science.1061964","article-title":"An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.","volume":"293","author":"Schiemann","year":"2001","journal-title":"Science"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.coi.2004.02.001","article-title":"Plasma cell differentiation and multiple myeloma.","volume":"16","author":"Shapiro-Shelef","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd1982","article-title":"An APRIL to remember: novel TNF ligands as therapeutic targets.","volume":"5","author":"Dillon","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/ajt.13557","article-title":"Effect of treatment with tabalumab, a B cell-activating factor inhibitor, on highly sensitized patients with end-stage renal disease awaiting transplantation.","volume":"16","author":"Mujtaba","year":"2016","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/S0140-6736(18)30984-X","article-title":"Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.","volume":"391","author":"Banham","year":"2018","journal-title":"Lancet"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets.","volume":"20","author":"Allman","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/ajt.12674","article-title":"Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation.","volume":"14","author":"Huang","year":"2014","journal-title":"Am J Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-6143.2008.02463.x","article-title":"Nox-2 is a modulator of fibrogenesis in kidney allografts.","volume":"9","author":"Djamali","year":"2009","journal-title":"Am J Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"F707","DOI":"10.1152\/ajprenal.90240.2008","article-title":"HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis.","volume":"295","author":"Vidyasagar","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/TP.0000000000002010","article-title":"Complete B cell deficiency reduces allograft inflammation and intragraft macrophages in a rat kidney transplant model.","volume":"102","author":"Panzer","year":"2018","journal-title":"Transplantation"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells.","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.4049\/jimmunol.180.6.3655","article-title":"Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.","volume":"180","author":"Benson","year":"2008","journal-title":"J Immunol"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells.","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J Exp Med"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ajt.13045","article-title":"Neutralizing BAFF\/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.","volume":"15","author":"Kwun","year":"2015","journal-title":"Am J Transplant"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances.","volume":"18","author":"Liu","year":"2012","journal-title":"Nat Med"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.34400","article-title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.","volume":"64","author":"Stohl","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/eji.201746934","article-title":"A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.","volume":"47","author":"Haselmayer","year":"2017","journal-title":"Eur J Immunol"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/89782","article-title":"TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice.","volume":"2","author":"Wang","year":"2001","journal-title":"Nat Immunol"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans.","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/ajt.13480","article-title":"Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.","volume":"15","author":"Newell","year":"2015","journal-title":"Am J Transplant"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ajt.13122","article-title":"Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study.","volume":"15","author":"Shabir","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:28:06Z","timestamp":1696224486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002686","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}